Hepatitis B in Moroccan health care workers

Occupational Medicine

Volumn 58, Issue 6, 2008, Pages 419-424

  Djeriri, K ^a   Laurichesse, H ^a,b   Merle, J l ^a   Charof, R ^c   Abouyoub, A ^d   Fontana, L ^a,b   Benchemsi, N ^d   Elharti, E ^d   El aouad, R ^c   Chamoux, A ^a,b   Beytout, J ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^d IBN SINA HOSPITAL   (Morocco)

Author keywords

Cross sectional study; HBV seroprevalence; HBV vaccine coverage; Health care workers; Hepatitis B; Intermediate endemicity; Knowledge; Morocco Rabat

Indexed keywords

ENGERIX B 20; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE STATUS; IMMUNITY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MIDWIFE; MOROCCO; NURSE; NURSING ASSISTANT; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; SELF CONCEPT; SEROLOGY; SEROPREVALENCE; VACCINATION; VIRUS TRANSMISSION;

ACCIDENTS, OCCUPATIONAL; ADULT; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MOROCCO; SEROEPIDEMIOLOGIC STUDIES;

EID: 51749118002     PISSN: 09627480     EISSN: 14718405     Source Type: Journal    
DOI: 10.1093/occmed/kqn071     Document Type: Article

References (22)

1. Mulley AG, Silverstein MD, Dienstag JL. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med 1982;307:644-652.
2. Djeriri K, Fontana L, Laurichesse H et al. Séroprévalence des marqueurs des hépatites virales au CHU de Clermont-Ferrand. Presse Med 1996;25:145-150.
3. Nejmi S, Coursaget P, D'Khissy D, Barres JL, Chiron JP. Prévalence des infections par les virus des hépatites A et B au Maroc. Presse Med 1984;13:1786-1787.
4. Zouhdi M, Moustakhir M, El Alaoui MA. Prévalence des marqueurs sériques des hépatites virales B et C chez les donneurs de sang au CRTS de Rabat (1995-1996). Biologie-Infectiologie 1997;2 12-21.
5. Rioche M. Prevalence of markers of the HBs system of hepatitis B among hospital personnel in Morocco: Evaluation of the risk of hepatitis B infection. Bull Soc Pathol Exot Filiales 1987;80:745-750.
6. Bourquia A, Benslimane A, Kafih M. Vaccination contre l'hépatite virale B: Evaluation de l'efficacité dans une population soignante hospitalière à haut risque. Rev Maroc Méd Santé 1987;1:35-38.
7. Djeriri K, Charof R, Laurichesse H et al. Comportement et conditions de travail exposant au sang: Analyse des pratiques dans trois établissements de soins au Maroc. Med Mal Infect 2005;35 396-401.
8. Hossini CH, Tripodi D, Rahhali AE et al. Knowledge and attitudes of health care professionals with respect to AIDS and the risk of occupational transmission of HIV in 2 Moroccan hospitals. Sante 2000;10:315-321.
9. Ascherio A, Zhang SM, Hernan MA et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Eng J Med 2001;344:327-332.
10. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S. Vaccines in multiple sclerosis study group. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Eng J Med 2001;344:319-326.
11. Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004;63:838-842.
12. Zeeshan M, Jabeen K, Ali ANA et al. Evaluation of immune response to hepatitis B in health care workers at a tertiary care hospital in Pakistan: An observational prospective study. BMC Infect Dis 2007;7:120.
13. Trevisan A, Paruzzolo P. Prevalence of hepatitis B virus infection in a population exposed to biological risk. J Occup Health 2000;42 341-344.
14. Smith NAL. Management of hepatitis B immunizations and blood exposure incidents in primary care. Occup Med (Lond) 2004;54:231-237.
15. Krishnan P, Dick F, Murphy E. The impact of educational interventions on primary health care worker's knowledge of occupational exposure to blood or body fluids. Occup Med (Lond) 2007;57:98-103.
16. Sabido M, Gavalda L, Olona N, Ramon JM. Timing of hepatitis B vaccination: Its effect on vaccine response in health care workers. Vaccine 2007;25:7568-7572.
17. Jilg W, Schmidt M, Deinhardt F. Decline of anti-HBs after hepatitis B vaccination and timings of revaccination. Lancet 1990;335 173-174.
18. Craven DE, Awdeh ZL, Kunches LM et al. Non responsiveness to hepatitis B vaccine in health care workers. Ann Intern Med 1986; 105:356-360.
19. Margolis HS, Presson AC. Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early. J Am Med Assoc 1993;270: 2971-2972.
20. Wood RC, MacDonald KL, White KE et al. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. J Am Med Assoc 1993;270:2935-2939.
21. Murphy E. Hepatitis B, vaccination and healthcare workers. Occup Med (Lond) 2000;50:383-386.
22. Mast EE, Weinbaum CM, Fiore AE et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR Morb Mortal Wkly Rep 2006;55:1-39.